Tony Ferrante received his BA in physics from Yale University and his MD and PhD degrees from the Albert Einstein College of Medicine. After completing his training in internal medicine at New York Presbyterian Hospital/Columbia University Medical Center, he performed post-doctoral studies with Rudy Leibel. He subsequently joined the Naomi Berrie Diabetes Center at Columbia University where he is the Dorothy and Daniel Silberberg Assistant Professor of Medicine.

Dr. Ferrante’s laboratory studies the role of immune cells in metabolic function. Studies from his laboratory revealed that obesity leads to a recruitment of immune cells to adipose tissue, so that in the most obese rodents and humans ~50% of the cells in an adipose tissue depot are macrophages. Current studies focus on the ways in which immune cells modulate the metabolic function of adipocytes, hepatocytes and other central metabolic cells.